Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: (probability or probabilistic)
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
6
of
6
Search:
'(probability or probabilistic)'
,
query time: 0.17s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Given issues with the stability of the sponsor's
probabilistic
analysis (i.e., wide variation...
”
Read Now
2
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Given issues with the stability of the sponsor's
probabilistic
analysis (i.e., wide variation...
”
Read Now
3
Pharmacoeconomic report: Eculizumab (Soliris) : Alexion Pharma Canada Corporation : indication : adult patients with generalized myasthenia gravis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... of $1,505,712 per quality-adjusted life-year (QALY) gained and has a 0%
probability
of being cost-effective...
”
Read Now
4
Brain electrical activity mapping for diagnosing psychiatric disorders : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
5
Brain electrical activity mapping for diagnosing psychiatric disorders : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
6
Pharmacoeconomic review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... review of available clinical trial data. The same transition
probabilities
for eliglustat and the ERTs...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
3
330 - Economics
3
612 - Human physiology
2
610 - Medicine & health
1
Language
English
6
Collection
National Center for Biotechnology Information
6
Author
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%28probability+or+probabilistic%29&type=AllFields
Send by Email
×
Loading...